Dasotraline
Catalog No: 16071017
CAS Number: 675126-05-3
Purity: 98% by HPLC
Dasotraline, also known as SEP-225,289, is a serotonin-norepinephrine-dopamine reuptake inhibitor (SNDRI) that is under development by Sunovion for clinical use. The drug is no longer being developed for major depressive disorder (MDD), but is still under investigation for the treatment of attention-deficit hyperactivity disorder (ADHD) and eating disorders.
For research use only. We do not sell to patients.
Chemical Information
| Name | Dasotraline |
|---|---|
| Iupac Chemical Name | (1R,4S)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydronaphthalen-1-amine |
| Synonyms | SEP-225,289; |
| Molecular Formula | C16H15Cl2N |
| Molecular Weight | 292.203 |
| Smile | ClC=1C=C(C=CC1Cl)[C@@H]1CC[C@H](C2=CC=CC=C12)N |
| InChiKey | SRPXSILJHWNFMK-MEDUHNTESA-N |
| InChi | InChI=1S/C16H15Cl2N/c17-14-7-5-10(9-15(14)18)11-6-8-16(19)13-4-2-1-3-12(11)13/h1-5,7,9,11,16H,6,8,19H2/t11-,16+/m0/s1 |
| CAS Number | 675126-05-3 |
| Related CAS |
Ordering Information
| Packaging | Price | Availability | Purity | Shipping Time |
|---|---|---|---|---|
| Bulk | Enquiry | Enquiry | Enquiry |
| Formulation | Solid powder |
|---|---|
| Purity | 98% by HPLC |
| Storage | -20 ºC for 3 years |
| Solubility | Soluble in DMSO |
| Handling | |
| Shipping Condition | Shipped under ambient temperature |
| HS Code |
Coming soon.
| Targets | |
|---|---|
| Mechanism | |
| Cell study | |
| Animal study | |
| Clinical study |
Not available
Chemical Structure
